Page last updated: 2024-10-19

nitrates and Parkinson Disease

nitrates has been researched along with Parkinson Disease in 28 studies

Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research Excerpts

ExcerptRelevanceReference
"To investigate whether nitric oxide (NO) plays a role in degenerative neurologic disease (DND), we measured nitrite, nitrate and cyclic GMP in cerebrospinal fluid (CSF) samples from patients with Parkinson's disease (PD), spinocerebellar ataxia (SCA) and amyotrophic lateral sclerosis (ALS)."3.69Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases. ( Ikeda, M; Miyatake, T; Murota, S; Sato, I; Yuasa, T, 1995)
"Alzheimer's (AD) and Parkinson's diseases (PD) are late-onset neurodegenerative diseases that have tremendous impact on the lives of affected individuals, their families, and society as a whole."2.41The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. ( Giasson, BI; Ischiropoulos, H; Lee, VM; Trojanowski, JQ, 2002)
"The pathology of Parkinson's disease (PD) is characterized by the degeneration of the nigrostriatal dopaminergic pathway, as well as the formation of intraneuronal inclusions known as Lewy bodies and Lewy neurites in the substantia nigra."1.36Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats. ( He, C; Hu, C; Xiang, Z; Xu, X; Yu, Z; Zhang, Z; Zhou, J, 2010)
"Syncope due to orthostatic hypotension (OH) refers to loss of consciousness caused by hypotension induced by the upright position; it is an important risk factor for fall-related physical injuries, especially in the elderly adults."1.35Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness. ( Bartoletti, A; Brignole, M; Furlan, R; Giada, F; Lagi, A; Maggi, R; Menozzi, C; Mussi, C; Ponassi, I; Re, G; Salvioli, G; Ungar, A, 2009)
"In brains from victims of Parkinson's disease, a nitrosyl species, identified as nitrosyl hemoglobin, has been observed in substantia nigra."1.30Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide. ( Ananda Inalsingh, V; Cammack, R; Hughes, MN; Shergill, JK, 1998)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (42.86)18.2507
2000's11 (39.29)29.6817
2010's4 (14.29)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Hu, X1
Hu, R1
Zhu, H1
Chen, Q1
Lu, Y1
Chen, J1
Liu, Y1
Chen, H1
Burai, R1
Ait-Bouziad, N1
Chiki, A1
Lashuel, HA1
Mussi, C1
Ungar, A1
Salvioli, G1
Menozzi, C1
Bartoletti, A1
Giada, F1
Lagi, A1
Ponassi, I1
Re, G1
Furlan, R1
Maggi, R1
Brignole, M1
Danielson, SR1
Held, JM1
Schilling, B1
Oo, M1
Gibson, BW1
Andersen, JK1
Yu, Z1
Xu, X1
Xiang, Z1
Zhou, J1
Zhang, Z1
Hu, C1
He, C1
Sevcsik, E1
Trexler, AJ1
Dunn, JM1
Rhoades, E1
Kabiraj, P1
Pal, R1
Varela-Ramirez, A1
Miranda, M1
Narayan, M1
Levecque, C1
Elbaz, A1
Clavel, J1
Richard, F1
Vidal, JS1
Amouyel, P1
Tzourio, C1
Alpérovitch, A1
Chartier-Harlin, MC1
Mishizen-Eberz, AJ1
Norris, EH1
Giasson, BI2
Hodara, R1
Ischiropoulos, H2
Lee, VM2
Trojanowski, JQ2
Lynch, DR1
Shavali, S1
Combs, CK1
Ebadi, M1
Shukla, R1
Rajani, M1
Srivastava, N1
Barthwal, MK1
Dikshit, M1
Reynolds, MR1
Berry, RW1
Binder, LI1
Reynolds, AD1
Kadiu, I1
Garg, SK1
Glanzer, JG1
Nordgren, T1
Ciborowski, P1
Banerjee, R1
Gendelman, HE1
Molina, JA1
Jiménez-Jiménez, FJ1
Navarro, JA1
Ruiz, E1
Arenas, J1
Cabrera-Valdivia, F1
Vázquez, A1
Fernández-Calle, P1
Ayuso-Peralta, L1
Rabasa, M1
Kuiper, MA1
Visser, JJ1
Bergmans, PL1
Scheltens, P1
Wolters, EC1
Ikeda, M1
Sato, I1
Yuasa, T1
Miyatake, T1
Murota, S1
Sawada, H1
Shimohama, S1
Kawamura, T1
Akaike, A1
Kitamura, Y1
Taniguchi, T1
Kimura, J1
Alam, ZI1
Jenner, A1
Daniel, SE1
Lees, AJ1
Cairns, N1
Marsden, CD1
Jenner, P2
Halliwell, B2
Dawson, VL1
Dawson, TM1
Cammack, R1
Shergill, JK1
Ananda Inalsingh, V1
Hughes, MN1
Marshall, KA1
Reist, M1
Torreilles, F1
Salman-Tabcheh, S1
Guérin, M1
Torreilles, J1
Pennathur, S1
Jackson-Lewis, V1
Przedborski, S1
Heinecke, JW1
LaVoie, MJ1
Hastings, TG1
Maruyama, W1
Naoi, M1
Aoyama, K1
Matsubara, K1
Fujikawa, Y1
Nagahiro, Y1
Shimizu, K1
Umegae, N1
Hayase, N1
Shiono, H1
Kobayashi, S1
Gatto, EM1
Riobó, NA1
Carreras, MC1
Cherñavsky, A1
Rubio, A1
Satz, ML1
Poderoso, JJ1

Reviews

4 reviews available for nitrates and Parkinson Disease

ArticleYear
Nitration in neurodegeneration: deciphering the "Hows" "nYs".
    Biochemistry, 2007, Jun-26, Volume: 46, Issue:25

    Topics: alpha-Synuclein; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Nitrates; Parkin

2007
Nitric oxide in neurodegeneration.
    Progress in brain research, 1998, Volume: 118

    Topics: AIDS Dementia Complex; Animals; Cerebrovascular Disorders; Humans; Neurodegenerative Diseases; Neuro

1998
Neurodegenerative disorders: the role of peroxynitrite.
    Brain research. Brain research reviews, 1999, Volume: 30, Issue:2

    Topics: Alzheimer Disease; Animals; Central Nervous System; Humans; Inflammation; Motor Neuron Disease; Mult

1999
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
    Free radical biology & medicine, 2002, Jun-15, Volume: 32, Issue:12

    Topics: Alzheimer Disease; Brain; Free Radicals; Humans; Neurons; Nitrates; Oxidation-Reduction; Oxidative S

2002

Other Studies

24 other studies available for nitrates and Parkinson Disease

ArticleYear
Nanozyme-based cascade SPR signal amplification for immunosensing of nitrated alpha-synuclein.
    Mikrochimica acta, 2022, 09-02, Volume: 189, Issue:10

    Topics: alpha-Synuclein; Biomarkers; Biosensing Techniques; Gold; Humans; Immunoassay; Metal Nanoparticles;

2022
Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Journal of the American Chemical Society, 2015, Apr-22, Volume: 137, Issue:15

    Topics: alpha-Synuclein; Humans; Molecular Structure; Mutagenesis; Nitrates; Parkinson Disease; Protein Proc

2015
Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2009, Volume: 64, Issue:7

    Topics: Accidental Falls; Aged; Aged, 80 and over; Digoxin; Diuretics; Electrocardiography; Emergency Servic

2009
Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.
    Analytical chemistry, 2009, Sep-15, Volume: 81, Issue:18

    Topics: alpha-Synuclein; Animals; Lewy Bodies; Mass Spectrometry; Models, Biological; Monoamine Oxidase; Nit

2009
Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.
    PloS one, 2010, Apr-08, Volume: 5, Issue:4

    Topics: alpha-Synuclein; Animals; Cell Death; Cells, Cultured; Dopamine; Down-Regulation; Gait Disorders, Ne

2010
Allostery in a disordered protein: oxidative modifications to α-synuclein act distally to regulate membrane binding.
    Journal of the American Chemical Society, 2011, May-11, Volume: 133, Issue:18

    Topics: Allosteric Regulation; alpha-Synuclein; Humans; Hydrodynamics; Lipid Bilayers; Membrane Lipids; Muta

2011
Nitrosative stress mediated misfolded protein aggregation mitigated by Na-D-β-hydroxybutyrate intervention.
    Biochemical and biophysical research communications, 2012, Sep-28, Volume: 426, Issue:3

    Topics: 3-Hydroxybutyric Acid; Apoptosis; Carrier Proteins; Caspases; Cell Line, Tumor; Dopaminergic Neurons

2012
Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study.
    Human molecular genetics, 2003, Jan-01, Volume: 12, Issue:1

    Topics: Case-Control Studies; Genetic Predisposition to Disease; Humans; Neutrophils; Nitrates; Nitric Oxide

2003
Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Biochemistry, 2005, May-31, Volume: 44, Issue:21

    Topics: alpha-Synuclein; Calpain; Chymotrypsin; Humans; Hydrolysis; Microscopy, Immunoelectron; Nerve Degene

2005
Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
    Neurochemical research, 2006, Volume: 31, Issue:1

    Topics: alpha-Synuclein; Animals; Cells, Cultured; Coculture Techniques; Dopamine; Humans; Lipopolysaccharid

2006
Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    The International journal of neuroscience, 2006, Volume: 116, Issue:12

    Topics: Female; Free Radicals; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nitrates; Nit

2006
Nitrated alpha-synuclein and microglial neuroregulatory activities.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2008, Volume: 3, Issue:2

    Topics: alpha-Synuclein; Animals; Cathepsin B; Cells, Cultured; Cystatins; Cysteine; Cytoskeletal Proteins;

2008
Plasma levels of nitrates in patients with Parkinson's disease.
    Journal of the neurological sciences, 1994, Dec-01, Volume: 127, Issue:1

    Topics: Aged; Antiparkinson Agents; Case-Control Studies; Female; Humans; Male; Nitrates; Nitric Oxide; Park

1994
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients.
    Journal of the neurological sciences, 1994, Volume: 121, Issue:1

    Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Female; Humans; Male; Middle Aged; Nerve Degeneration; N

1994
Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.
    Journal of neural transmission. General section, 1995, Volume: 100, Issue:3

    Topics: Aged; Amyotrophic Lateral Sclerosis; Biomarkers; Cyclic GMP; Female; Humans; Male; Middle Aged; Nerv

1995
Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons.
    Journal of neuroscience research, 1996, Nov-15, Volume: 46, Issue:4

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Ascorbic Acid; Cell Survival; Cells, Cultured; D

1996
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.
    Journal of neurochemistry, 1997, Volume: 69, Issue:3

    Topics: Aged; Aged, 80 and over; Aging; Base Composition; DNA; DNA Damage; Gas Chromatography-Mass Spectrome

1997
Applications of electron paramagnetic resonance spectroscopy to study interactions of iron proteins in cells with nitric oxide.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 1998, Volume: 54A, Issue:14

    Topics: Animals; Bacteria; Cysteine; Electron Spin Resonance Spectroscopy; Food Preservation; Hemeproteins;

1998
The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease.
    Free radical biology & medicine, 1999, Volume: 27, Issue:5-6

    Topics: Animals; Cell Line; Cell Survival; Glutathione; Neurons; Nitrates; Parkinson Disease; Rats; Substant

1999
Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
    The Journal of biological chemistry, 1999, Dec-03, Volume: 274, Issue:49

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain; Chelating Agents; Dopamin

1999
Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss.
    Journal of neurochemistry, 1999, Volume: 73, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcohol Dehydrogenase; Antioxidants; Apoptosis; Catala

1999
Neuroprotection by (-)-deprenyl and related compounds.
    Mechanisms of ageing and development, 1999, Volume: 111, Issue:2-3

    Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Mo

1999
Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
    Annals of neurology, 2000, Volume: 47, Issue:4

    Topics: Adult; Aged; Alzheimer Disease; Antibodies; Biomarkers; Female; Humans; Male; Middle Aged; Nitrates;

2000
Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease.
    Nitric oxide : biology and chemistry, 2000, Volume: 4, Issue:5

    Topics: Blotting, Western; Enzyme Induction; Female; Humans; Hydrogen Peroxide; Male; Middle Aged; Neutrophi

2000